布地奈德混悬液联合异丙托溴铵雾化治疗小儿支气管肺炎的疗效分析

Analysis of the Efficacy of Budesonide Combined Ipratropium Bromide Nebulizer in Treatment of Children with Bronchial Pneumonia

目的:探讨布地奈德混悬液与异丙托溴铵雾化治疗小儿支气管肺炎的临床疗效。方法:选择笔者所在医院2011年6月-2013年9月收治的100例小儿支气管肺炎患儿为研究对象,按照随机数字表法分为对照组和观察组,每组50例。两组患儿都采取基础治疗,对照组加用布地纳德混悬液行吸入雾化治疗,观察组加用布地纳德与异丙托溴铵雾化治疗,对两组患儿的临床治疗效果进行对比分析。结果:观察组患儿治疗总有效率为90.00%,明显优于对照组的72.00%,两组比较差异有统计学意义(P<0.05)。观察组患儿气促、咳嗽、细湿啰音等体征消失时间显著短于对照组,两组比较差异有统计学意义(P<0.05)。结论:对小儿支气管肺炎采取布地奈德和异丙托溴铵雾化治疗效果显著,安全性高,术后无明显不良反应,值得临床进一步推广使用。

Objective：To investigate the clinical efficacy of budesonide and ipratropium bromide nebulizer treatment of children with bronchial pneumonia. Method：100 patients with bronchial pneumonia in children in our hospital from June 2011 to September 2013 admitted for the study,were randomly divided into the control group and the observation group,each group of 50 cases.Two group patients have taken the basic treatment,the control group household budesonide inhalation suspension line atomization treatment,observation group were treated with budesonide and ipratropium bromide nebulizer treatment,than the clinical effects were analyzed.Result：The effective rate of the control group was 72.00%while the observation group was 90.00%after treatment,and the difference between the two groups was statistically significant（P〈0.05）.The shortness of breath,cough,rales disappeared time for clinical treatment of the observation group were significantly less than the control group（P〈0.05）.Conclusion：Bronchial pneumonia in children taking budesonide and ipratropium bromide nebulizer treatment effect is remarkable,safe,no significant adverse reactions after surgery,worthy of further promotion use.